ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,086.37
0.61%
US Tech 100
21,214.46
1.06%
다우존스 지수
44,156.73
0.30%
Bitcoin
102,394.93
-1.20%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 독일
  5. TG

  6. COSMO Pharmaceuticals NV (C43) 시세

COSMO Pharmaceuticals NV

COSMO Pharmaceuticals NV (C43)

TG
69.50
0.00
(0.00%)
마감 23 1월 6:00AM
실시간 데이터

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

프리미엄

주요 통계 및 세부정보

가격
69.50
매수가
69.00
매도가
69.50
거래량
37
69.50 일간 변동폭 70.00
59.00 52주 범위 87.00
market_cap
1.13B
전일 종가
69.50
개장가
69.50
최근 거래 시간
34
@
69.5
마지막 거래 시간
재정 규모
-
VWAP
-
평균 볼륨(3m)
78
발행 주식
16,260,132
배당수익률
2.88%
주가수익률
-418.40
주당순이익(EPS)
-0.3
매출
94.23M
순이익
-4.93M

COSMO Pharmaceuticals NV 정보

섹터
Pharmaceutical Preparations
산업
Medicinal Chems,botanicl Pds
웹사이트
www.cosmopharmaceuticals.com
본부
Dublin, Irl
설립됨
1997
COSMO Pharmaceuticals NV is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker C43. The last closing price for COSMO Pharmaceuticals NV was 69.50 €. Over the last year, COSMO Pharmaceuticals NV shares have traded in a share price range of 59.00 € to 87.00 €.

COSMO Pharmaceuticals NV currently has 16,260,132 shares in issue. The market capitalisation of COSMO Pharmaceuticals NV is 1.13 € billion. COSMO Pharmaceuticals NV has a price to earnings ratio (PE ratio) of -418.40.

C43 최신 뉴스

추가 뉴스
No news to show yet.
기간변동변동 %시가고가저가평균 일일 거래량VWAP
11.52.205882352946870684368.39230769DE
446.1068702290165.570644967.69984326DE
12-3-4.1379310344872.574627866.65498254DE
26-1.5-2.112676056347187626372.36575537DE
522.53.731343283586787598371.73737821DE
15617.533.6538461538528741.610358.80798817DE
260-14-16.766467065983.58741.610662.27293591DE

C43 - Frequently Asked Questions (FAQ)

What is the current COSMO Pharmaceuticals NV share price?
The current share price of COSMO Pharmaceuticals NV is 69.50 €
How many COSMO Pharmaceuticals NV shares are in issue?
COSMO Pharmaceuticals NV has 16,260,132 shares in issue
What is the market cap of COSMO Pharmaceuticals NV?
The market capitalisation of COSMO Pharmaceuticals NV is EUR 1.13B
What is the 1 year trading range for COSMO Pharmaceuticals NV share price?
COSMO Pharmaceuticals NV has traded in the range of 59.00 € to 87.00 € during the past year
What is the PE ratio of COSMO Pharmaceuticals NV?
The price to earnings ratio of COSMO Pharmaceuticals NV is -418.4
What is the cash to sales ratio of COSMO Pharmaceuticals NV?
The cash to sales ratio of COSMO Pharmaceuticals NV is 21.9
What is the reporting currency for COSMO Pharmaceuticals NV?
COSMO Pharmaceuticals NV reports financial results in EUR
What is the latest annual turnover for COSMO Pharmaceuticals NV?
The latest annual turnover of COSMO Pharmaceuticals NV is EUR 94.23M
What is the latest annual profit for COSMO Pharmaceuticals NV?
The latest annual profit of COSMO Pharmaceuticals NV is EUR -4.93M
What is the registered address of COSMO Pharmaceuticals NV?
The registered address for COSMO Pharmaceuticals NV is RIVERSIDE II, SIR JOHN ROGERSON’S QUAY, DUBLIN, 20020
What is the COSMO Pharmaceuticals NV website address?
The website address for COSMO Pharmaceuticals NV is www.cosmopharmaceuticals.com
Which industry sector does COSMO Pharmaceuticals NV operate in?
COSMO Pharmaceuticals NV operates in the MEDICINAL CHEMS,BOTANICL PDS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
PNYPine Technology Holdings Ltd
0.0065 €
(44.44%)
35k
AAHAhlers AG
0.01 €
(42.86%)
12k
38ERekor Systems Inc
1.984 €
(32.09%)
39.11k
L7C2Windfall Geotek Inc
0.011 €
(29.41%)
11.72k
9AJ1Altiplano Metals Inc
0.0438 €
(28.82%)
13.61k
432Arbor Metals Corp
0.318 €
(-43.82%)
2.11M
PQWNPacific Ridge Exploration Ltd
0.007 €
(-41.67%)
36.12k
BDDOrdinary Shares
0.0034 €
(-41.38%)
10.6k
R1EAEV Resources Ltd
0.0012 €
(-40.01%)
6.08k
E3O1Nexoptic Technology Corp
0.0095 €
(-38.71%)
12.79k
D7GNel ASA
0.1905 €
(-1.55%)
4.93M
PF8European Lithium Limited
0.0408 €
(-8.11%)
3.57M
RQ0DWave Quantum Inc
6.016 €
(-0.76%)
3.27M
SHA0Schaeffler AG
3.96 €
(-9.02%)
2.31M
24YBrainchip Holdings Ltd
0.2318 €
(14.19%)
2.19M

토론

전체 피드 보기
weedtrader420 weedtrader420 2 분 전
BITCOIN XRP AIMAW Aqualung💦Cross eyed Mary $120,000 TARGET ✊😮‍💨☝️
BTCUSD
Saving Grace Saving Grace 4 분 전
Yes, when NDA's are removed, it's boom time. Everyone at the plant is excited and ready.

https://businessjournaldaily.com/wp-content/uploads/2024/10/Foxconn-Model-C-EV.jpg

https://i.vimeocdn.com/video/1780032285-1eadf9821975b71cc554aa3a7d443a4b59265d9b3a16081b2573d7c443
NRDE
ThoroughBread ThoroughBread 6 분 전
SFIO .0028 sleeper.
SFIO
glens0 glens0 7 분 전
CTOR last Aug. 6th the price was $49.00 now $1.32
CTOR
ThoroughBread ThoroughBread 9 분 전
SING @ .006 bounce-pop off this level. Daily volume increasing.
boi568 boi568 9 분 전
Yes, it's also true that guidelines allow for more discretion than rules. To a point.

If the governing science that applies to two applicants is the same, the FDA decisional criteria should be the same. In this case, if the AD stages in the trials are the same, the endpoints should be
AVXL
Hardazoak Hardazoak 11 분 전
Current Aabbg works fine, wallet works fine. New aabb wallet 2.0 with AI and moonpay exchange integrated coming. Stop with the lies gitreal, only you are believing your own lies.
AABB
KPIFF-LDDFF KPIFF-LDDFF 11 분 전
KPIFF
wadegarret wadegarret 11 분 전
Novice- AI stocks have mostly done their thing

I don't believe Stargate will add all that much to boost valuations further. I mean NVDA already sells for over a 30 something PE going forward, CRDO sells for an 85 PE going forward, CRWD sells for around an 80 PE going forward, PLTR
AES CRDO CRWD
PEACHMAN PEACHMAN 12 분 전
The exact opposite of what you say is true.LOLOLOLOL!!!!! I OWN you, kitty. Heart, mind, body and soul!! You fall into traps, you copy verbatim my posts. Have you ever had an independent thought in your life?

https://investorshub.advfn.com/uimage/uploads/2025/1/22/sdlmono_panther.pn
IFUS
pinhigh pinhigh 12 분 전
Well done video gimmee! RRX!
BIEL
Orange Cassidy Orange Cassidy 14 분 전
The Jared "whisperer" is still here in emoji form on every post. He has not gone anywhere. As it stands the mills are abandoned and this is still a sham. "Whats not to like?"
NBRI
bas2020 bas2020 14 분 전
Any shorting after approval will be total manipulation by the corrupt cabal... your bosses. Hopefully, we'll have MTD denial prior with a cease and desist order to go with it... to cut ya all off at the knees. 💥
NWBO
hssbwwmp hssbwwmp 14 분 전
Yes, I've seen them cite those factors in their reports as well as being flexible to adapt to them. So, it would seem that if AXXA was still able to grow revenue and reduce debt despite those factors, then the PPS should not have continued this long downtrend, correct? Something still is not comp
AXXA
RichieBoy RichieBoy 15 분 전
Minute 28 - Minute 40 is on AI

Keep in mind this is acutely political. So you'll be left wondering about this side of AI and oh that part of AI why aren't they important. They are important of course, but never before to date will you have seen such intense focus on this one facet.
AFFU
boarddork boarddork 16 분 전
That’s a lot of push pins and zig zag strings to make that ultimate conclusion.
COOP
weedtrader420 weedtrader420 17 분 전
BITCOIN XRP TRIUMPH MAGIC POWER $120,000 TARGET
BTCUSD
janice shell janice shell 17 분 전
She's one of the very few who actually deserves a pardon.
Hoskuld Hoskuld 18 분 전
This is not really true Boi - although I can imagine that logically it should be true. But, no 2 companies run their trials the same way. Usually. this is deliberate. The FDA cannot evaluate them the same way, as a result. The guidelines are NOT requirements. They are simply suggestions.
AVXL
StayHumble StayHumble 19 분 전
wow💹100% Xpert SHORT interest💹significant evidence of SHORTS💹💹 huzzah!!!
HMBL
WALL STREET KID WALL STREET KID 19 분 전
$AMC 5B SWAPS EXPIRING! SHORTS AT RISK! Short Squeeze Update

https://youtu.be/eUD6PpQ-Oxw?si=QpOWsGLt0b2Qu2s6
AMC
vinmantoo vinmantoo 22 분 전
Jq1234, give Bluesky a try. It looks a lot like Twitter did but doesn’t have a controlling algorithm.
WhAtEvA1 WhAtEvA1 23 분 전
With 18 indications trial starting in India well ahead of US trials (and if proven successful) it won't take long when Vivos valuations will be trading forward. IMHO of course. It is worth bios do when efficacy data is strong and potential of approval in the public interest outweighs the risks.
RDGL

최근 히스토리

TG
C43
COSMO Pharmaceuticals NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유